Get startedLog in
    Picture of Quoin Pharmaceuticals logo

    QNRX — Quoin Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Cellect Biotechnology - Got Ind Application From FDA To Start Trial For Apograft Technology For Haploidentical Bone Marrow Transplantations

    Picture of Quoin Pharmaceuticals logoQuoin Pharmaceuticals
    06/11/2019 16:00
    Nov 6 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY - GOT IND APPLICATION FROM FDA TO
START
TRIAL FOR APOGRAFT TECHNOLOGY FOR HAPLOIDENTICAL BONE MARROW
TRANSPLANTATIONS

Source text: [https://bit.ly/34CuDBu]
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Quoin Pharmaceuticals

    See all news